Factors Analysis Related to Prolonged Stay in the Pediatric Post-Anesthesia Care Unit(PACU)

Anesthesia; Adverse Effect Clinical Trial

— PACU  

Official title:

Prolonged Stay in the Pediatric PACU

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT06396000
• Other study ID #: FARPSPP
• Status: Not yet recruiting
• Start date: May 31, 2024
• Est. completion date: March 31, 2025

Study information

• Verified date: May 2024
• Source: Tongji Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to determine which factors contribute to prolonged stay of children in the PACU.

Description:

Studying the factors associated with prolonged stay of children in the PACU is of great significance to the medical team, as it can improve the quality and speed of anesthesia recovery, not only in line with the concept of accelerated rehabilitation surgery, but also through intervention and optimization of specific factors to improve the efficiency of children's postoperative discharge from the PACU, reduce the incidence of complications, lower medical costs, and increase patient and family satisfaction. Therefore, this study aims to explore the factors associated with prolonged stay of children in the PACU through retrospective analysis.

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 10000
• Est. completion date: March 31, 2025
• Est. primary completion date: December 31, 2024
• Gender: All
• Age group: N/A to 18 Years

Eligibility

Inclusion Criteria:

• Children aged 0-18 years old; Child entering the Pediatric Post-Anesthesia Care.

• Emergency surgery; Pediatric patients with incomplete medical history; Pediatric patients requiring postoperative ICU care; Pediatric patients with preoperative altered consciousness; Neurological disorders; Severe liver, kidney, lung, and heart diseases.

Related Conditions & MeSH terms

• Anesthesia; Adverse Effect

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Saiqiang Guo

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Anesthesia Plan Selection	Anesthesia options include general anesthesia, combined anesthesia, pure intravenous anesthesia, and nerve block anesthesia.	Day 1
Primary	Pain Score	Evaluate pain using the Visual Analog Scale (VAS): 0 points: no pain; 1-3 points: mild pain; 4-6 points: moderate pain; 7-10 points: severe pain.	Day 1
Primary	Complications in PACU	Nausea, vomiting, chills, pain, agitation	Day 1
Primary	American Society of Anesthesiologists(ASA)	ASA I: Patients in good health, without systemic disease. ASA II: Patients with mild systemic disease, not significantly limiting daily activity.; ASA III: Patients with severe systemic disease, with definite functional limitation.; ASA IV: Patients with severe systemic disease that is a constant threat to life.; ASA V: Moribund patients who are not expected to survive without the operation. ASA VI: Brain-dead patients whose organs are being removed for donation.	Day 1
Primary	The medication usage in PACU	Morphine, Propofol, Ketorolac, Fentanyl	Day 1
Secondary	The use of PCA(Patient-Controlled Analgesia)in PACU	PCA usage statistics,yes or no	Day 1